cinoxacin has been researched along with Chronic Disease in 4 studies
Cinoxacin: Synthetic antimicrobial related to OXOLINIC ACID and NALIDIXIC ACID and used in URINARY TRACT INFECTIONS.
cinoxacin : A member of the class of cinnolines that is 6,7-methylenedioxycinnolin-4(1H)-one bearing an ethyl group at position 1 and a carboxylic acid group at position 3. An analogue of oxolinic acid, it has similar antibacterial actions. It was formerly used for the treatment of urinary tract infections.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cinoxacin was administered to 30 outpatients with chronic complicated urinary tract infection for 57." | 5.27 | [Clinical study on long-term cinoxacin therapy for outpatients with chronic complicated urinary tract infections]. ( Katoh, M; Matsumoto, J; Tada, S; Yamasaki, Y, 1985) |
| "Twenty-two patients with chronic complicated urinary tract infections were treated with 400 to 1,200 mg/day cinoxacin for 2 to 12 months." | 3.67 | [Long-term cinoxacin therapy for chronic complicated urinary tract infection]. ( Ueyama, H, 1984) |
| "Cinoxacin was administered to 30 outpatients with chronic complicated urinary tract infection for 57." | 1.27 | [Clinical study on long-term cinoxacin therapy for outpatients with chronic complicated urinary tract infections]. ( Katoh, M; Matsumoto, J; Tada, S; Yamasaki, Y, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ueyama, H | 1 |
| Briedigkeit, H | 1 |
| Schimmelpfennig, R | 1 |
| Buder, R | 1 |
| Precht, K | 1 |
| Dröseler, H | 1 |
| Hayashi, Y | 1 |
| Terao, E | 1 |
| Yamasaki, I | 1 |
| Matsumoto, J | 1 |
| Yamasaki, Y | 1 |
| Katoh, M | 1 |
| Tada, S | 1 |
1 trial available for cinoxacin and Chronic Disease
| Article | Year |
|---|---|
[A comparison of cinoxacin and nalidixic acid in the treatment of chronic urinary tract infections].
Topics: Bacteriuria; Chronic Disease; Cinoxacin; Cystitis; Gastrointestinal Diseases; Humans; Nalidixic Acid | 1982 |
3 other studies available for cinoxacin and Chronic Disease
| Article | Year |
|---|---|
[Long-term cinoxacin therapy for chronic complicated urinary tract infection].
Topics: Aged; Chronic Disease; Cinoxacin; Female; Humans; Male; Middle Aged; Pyridazines; Time Factors; Urin | 1984 |
[Study of clinical efficacy and safety of long-term cinoxacin therapy of chronic urogenital organ infection].
Topics: Adult; Aged; Chronic Disease; Cinoxacin; Drug Evaluation; Female; Humans; Male; Middle Aged; Prostat | 1987 |
[Clinical study on long-term cinoxacin therapy for outpatients with chronic complicated urinary tract infections].
Topics: Adult; Aged; Ambulatory Care; Chronic Disease; Cinoxacin; Drug Evaluation; Female; Humans; Male; Mid | 1985 |